Saliva-serum theophylline concentrations: substantial intrapatient and interpatient variation in predicting serum concentrations. 1981

D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske

The relationships between serum and saliva concentrations were evaluated in 18 patients after single doses of three theophylline preparations. Simultaneous multiple saliva and serum samples were obtained after theophylline ingestion and were analyzed for theophylline content by the modified Schack and Waxler spectrophotometric method. Significant variability was observed in the data for those saliva/serum ratio sets obtained within 30 min of dosage. The mean correlation coefficient for saliva/serum sample sets obtained at and after 30 min was 0.86. Pearson product moment correlation coefficients determined for saliva/serum ratios at 2,4,6, and 8 hr ranged from 0.84 to 0.89, leaving 26% of the variance unexplained. Serum concentrations were calculated from a randomly selected saliva/serum ratio for each patient. Predicted serum concentrations were +/- 2 micrograms/ml of measured concentrations in only 143 of the 196 determinations (73%). Therefore, the use of saliva concentrations to predict serum values has substantial error in specific patients and may lead to incorrect dosage adjustments.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D004304 Dosage Forms Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. Dosage Form,Form, Dosage,Forms, Dosage
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D013806 Theophylline A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. 1,3-Dimethylxanthine,3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione,Accurbron,Aerobin,Aerolate,Afonilum Retard,Aquaphyllin,Armophylline,Bronchoparat,Bronkodyl,Constant-T,Elixophyllin,Euphylong,Glycine Theophyllinate,Lodrane,Monospan,Nuelin,Nuelin S.A.,Quibron T-SR,Slo-Phyllin,Somophyllin-T,Sustaire,Synophylate,Theo Von Ct,Theo-24,Theo-Dur,Theobid,Theocin,Theoconfin Continuous,Theodur,Theolair,Theolix,Theon,Theonite,Theopek,Theophylline Anhydrous,Theophylline Sodium Glycinate,Theospan,Theostat,Theovent,Uniphyl,Uniphyllin,Uniphylline,1,3 Dimethylxanthine,Anhydrous, Theophylline,Constant T,ConstantT,Ct, Theo Von,Glycinate, Theophylline Sodium,Quibron T SR,Quibron TSR,Slo Phyllin,SloPhyllin,Sodium Glycinate, Theophylline,Somophyllin T,SomophyllinT,Theo 24,Theo Dur,Theo24,Theophyllinate, Glycine,Von Ct, Theo

Related Publications

D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske
March 1987, American journal of diseases of children (1960),
D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske
December 1985, British journal of clinical pharmacology,
D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske
January 1987, Clinical pharmacology and therapeutics,
D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske
September 2012, Journal of neuroscience methods,
D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske
June 2002, Therapeutic drug monitoring,
D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske
November 2001, International journal of radiation oncology, biology, physics,
D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske
April 1992, Therapeutic drug monitoring,
D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske
August 2017, The Canadian journal of cardiology,
D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske
January 1990, Pediatric pulmonology,
D L Uden, and K W Miller, and L M Strand, and P B Johnson, and D E Zaske
July 1978, Annals of allergy,
Copied contents to your clipboard!